Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Medicine Center of Excellence, |
RCV000171438 | SCV000221636 | likely benign | not specified | 2016-09-28 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001573566 | SCV003286458 | uncertain significance | not provided | 2022-06-14 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with CACNA1F-related conditions. This variant is present in population databases (rs781923569, gnomAD 0.008%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 70 of the CACNA1F protein (p.Arg70Gln). ClinVar contains an entry for this variant (Variation ID: 191248). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). |
Laboratory of Diagnostic Genome Analysis, |
RCV001573566 | SCV001799626 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001573566 | SCV001965111 | uncertain significance | not provided | no assertion criteria provided | clinical testing |